{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:21:19Z","timestamp":1785428479173,"version":"3.56.0"},"reference-count":126,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Departmental funds"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The coronavirus disease 2019 (COVID-19) pandemic has grown to be a global public health crisis with no safe and effective treatments available yet. Recent findings suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus pathogen that causes COVID-19, could elicit a cytokine storm that drives edema, dysfunction of the airway exchange, and acute respiratory distress syndrome in the lung, followed by acute cardiac injury and thromboembolic events leading to multiorgan failure and death. Mesenchymal stem cells (MSCs), owing to their powerful immunomodulatory abilities, have the potential to attenuate the cytokine storm and have therefore been proposed as a potential therapeutic approach for which several clinical trials are underway. Given that intravenous infusion of MSCs results in a significant trapping in the lung, MSC therapy could directly mitigate inflammation, protect alveolar epithelial cells, and reverse lung dysfunction by normalizing the pulmonary microenvironment and preventing pulmonary fibrosis. In this review, we present an overview and perspectives of the SARS-CoV-2 induced inflammatory dysfunction and the potential of MSC immunomodulation for the prevention and treatment of COVID-19 related pulmonary disease.<\/jats:p>","DOI":"10.1002\/stem.3354","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T06:05:41Z","timestamp":1637906741000},"page":"707-722","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm"],"prefix":"10.1093","volume":"39","author":[{"given":"Na","family":"Song","sequence":"first","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Rossignoli","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bhere","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Ciccocioppo","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Medicine, A.O.U.I. Policlinico G.B. Rossi & University of Verona , Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Siong","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasneet Kaur","family":"Khalsa","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Mastrolia","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia , Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Valeria","family":"Samarelli","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia , Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia , Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5474-0974","authenticated-orcid":false,"given":"Khalid","family":"Shah","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Harvard Stem Cell Institute, Harvard University , Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"2022061709080694700_stem3354-bib-0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"2022061709080694700_stem3354-bib-0002","article-title":"The science underlying COVID-19: implications for the cardiovascular system","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"2022061709080694700_stem3354-bib-0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"10223","key":"2022061709080694700_stem3354-bib-0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"13","key":"2022061709080694700_stem3354-bib-0007","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/acschemneuro.0c00346","article-title":"Cytokine storm in COVID19: a neural hypothesis","volume":"11","author":"Ur","year":"2020","journal-title":"ACS Chem Nerosci"},{"issue":"15","key":"2022061709080694700_stem3354-bib-0008","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10229","key":"2022061709080694700_stem3354-bib-0009","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2022061709080694700_stem3354-bib-0010","first-page":"E71","article-title":"Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use","volume":"23","author":"Atluri","year":"2020","journal-title":"Pain Physician"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0011","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-020-0791-5","article-title":"COVID-19 in the heart and the lungs: could we \u201cnotch\u201d the inflammatory storm?","volume":"115","author":"Rizzo","year":"2020","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"2022061709080694700_stem3354-bib-0013","doi-asserted-by":"crossref","first-page":"e1000604","DOI":"10.1371\/journal.ppat.1000604","article-title":"Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes","volume":"5","author":"Cilloniz","year":"2009","journal-title":"PLoS Pathog"},{"key":"2022061709080694700_stem3354-bib-0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1465-9921-11-147","article-title":"Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro","volume":"11","author":"Lee","year":"2010","journal-title":"Respir Res"},{"key":"2022061709080694700_stem3354-bib-0015","first-page":"1","article-title":"Mesenchymal stem cell therapy for COVID-19: present or future","author":"Golchin","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"2022061709080694700_stem3354-bib-0016","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discov"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11684-020-0773-x","article-title":"Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Med"},{"issue":"6","key":"2022061709080694700_stem3354-bib-0018","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"2022061709080694700_stem3354-bib-0019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"SI-1","key":"2022061709080694700_stem3354-bib-0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3906\/sag-2004-168","article-title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"2022061709080694700_stem3354-bib-0021","doi-asserted-by":"crossref","first-page":"108448","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin Immunol"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0022","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"2022061709080694700_stem3354-bib-0023","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/oby.22849","article-title":"Does high cardiorespiratory fitness confer some protection against proinflammatory responses after infection by SARS-CoV-2?","volume":"28","author":"Zbinden-Foncea","year":"2020","journal-title":"Obesity"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/08830185.2020.1756284","article-title":"Can melatonin reduce the severity of COVID-19 pandemic?","volume":"39","author":"Shneider","year":"2020","journal-title":"Int Rev Immunol"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0025","doi-asserted-by":"crossref","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection","volume":"9","author":"Guo","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022061709080694700_stem3354-bib-0026","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J Transl Med"},{"key":"2022061709080694700_stem3354-bib-0028","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.eng.2020.02.006","article-title":"Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection, a hint for COVID-19 treatment","volume":"6","author":"Chen","year":"2020","journal-title":"Engineering"},{"key":"2022061709080694700_stem3354-bib-0029","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3332\/ecancer.2020.1023","article-title":"COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"2022061709080694700_stem3354-bib-0030","volume-title":"First clinical use of lenzilumab to neutralize GM-CSF in patients with severe COVID-19 pneumonia. medRxiv","author":"Temesgen","year":"2020"},{"key":"2022061709080694700_stem3354-bib-0031","article-title":"Early combination of tocilizumab and corticosteroids: an upgrade in anti-inflammatory therapy for severe COVID","author":"Mart\u00ednez-Urbistondo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0032","first-page":"227","article-title":"Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence","volume":"5","author":"Teoh","year":"2020","journal-title":"J Clin Transl Res"},{"key":"2022061709080694700_stem3354-bib-0033","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2020.00857","article-title":"Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study","volume":"11","author":"Giudice","year":"2020","journal-title":"Front Pharmacol"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0034","doi-asserted-by":"crossref","first-page":"101303","DOI":"10.1016\/j.isci.2020.101303","article-title":"Current status of COVID-19 therapies and drug repositioning applications","volume":"23","author":"Altay","year":"2020","journal-title":"iScience"},{"key":"2022061709080694700_stem3354-bib-0035","volume-title":"StatPearls","author":"Saad","year":"2020"},{"key":"2022061709080694700_stem3354-bib-0036","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12916-015-0426-0","article-title":"Mesenchymal stem\/stromal cells as a delivery platform in cell and gene therapies","volume":"13","author":"D'Souza","year":"2015","journal-title":"BMC Med"},{"key":"2022061709080694700_stem3354-bib-0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2019.05.004","article-title":"Dissecting the pharmacodynamics and pharmacokinetics of MSCs to overcome limitations in their clinical translation","volume":"14","author":"Salvadori","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"9","key":"2022061709080694700_stem3354-bib-0038","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni.1637","article-title":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection","volume":"9","author":"Snelgrove","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3184\/003685010X12708191209250","article-title":"Mesenchymal stem cells as a platform for gene therapy protocols","volume":"93","author":"Dalberto","year":"2010","journal-title":"Sci Prog"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2022061709080694700_stem3354-bib-0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9214831","article-title":"Mesenchymal stem cell-based immunomodulation: properties and clinical application","volume":"2018","author":"Wang","year":"2018","journal-title":"Stem Cells Int"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0042","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","article-title":"Manufacturing of primed mesenchymal stromal cells for therapy","volume":"3","author":"Yin","year":"2019","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0043","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/jcm8071025","article-title":"The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity","volume":"8","author":"Zhou","year":"2019","journal-title":"J Clin Med"},{"issue":"13","key":"2022061709080694700_stem3354-bib-0044","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","article-title":"Interactions between mesenchymal stem cells and the immune system","volume":"74","author":"Li","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/sctm.19-0205","article-title":"Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome","volume":"9","author":"Abraham","year":"2020","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0046","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol Med"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0047","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","article-title":"Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy","volume":"12","author":"Wang","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2022061709080694700_stem3354-bib-0048","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0049","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13287-018-0802-8","article-title":"Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases","volume":"9","author":"Silva","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"2022061709080694700_stem3354-bib-0050","first-page":"317801","article-title":"Human umbilical cord mesenchymal stem cells inhibit the function of allogeneic activated V\u03b39V\u03b42 T lymphocytes in vitro","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"issue":"12","key":"2022061709080694700_stem3354-bib-0051","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/leu.2014.273","article-title":"Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells","volume":"28","author":"Malcherek","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0052","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","article-title":"Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses","volume":"112","author":"Karlsson","year":"2008","journal-title":"Blood"},{"key":"2022061709080694700_stem3354-bib-0053","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0054","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13063-020-04416-w","article-title":"Repair of acute respiratory distress syndrome by stromal cell administration in COVID-19 (REALIST-COVID-19): a structured summary of a study protocol for a randomised, controlled trial","volume":"21","author":"Gorman","year":"2020","journal-title":"Trials"},{"issue":"12","key":"2022061709080694700_stem3354-bib-0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"key":"2022061709080694700_stem3354-bib-0056","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41232-020-00121-y","article-title":"Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases","volume":"40","author":"Tsuchiya","year":"2020","journal-title":"Inflamm Regen"},{"issue":"10","key":"2022061709080694700_stem3354-bib-0057","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"issue":"9","key":"2022061709080694700_stem3354-bib-0058","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematologica"},{"key":"2022061709080694700_stem3354-bib-0059","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-015-0700-0","article-title":"Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study","volume":"13","author":"Reinders","year":"2015","journal-title":"J Transl Med"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0061","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/14653249.2010.507330","article-title":"Defining the risks of mesenchymal stromal cell therapy","volume":"12","author":"Prockop","year":"2010","journal-title":"Cytotherapy"},{"key":"2022061709080694700_stem3354-bib-0062","doi-asserted-by":"crossref","first-page":"5934782","DOI":"10.1155\/2016\/5934782","article-title":"iPSCs: a minireview from bench to bed, including organoids and the CRISPR system","volume":"2016","author":"Orqueda","year":"2016","journal-title":"Stem Cells Int"},{"key":"2022061709080694700_stem3354-bib-0063","article-title":"Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells","author":"Schafer","year":"2020","journal-title":"Stem Cell Reports"},{"key":"2022061709080694700_stem3354-bib-0064","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/sctm.20-0083","article-title":"Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019","volume":"9","author":"Ji","year":"2020","journal-title":"Stem Cells Translational Medicine"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/sctm.16-0415","article-title":"Concise review: mesenchymal stromal cell-based approaches for the treatment of acute respiratory distress and sepsis syndromes","volume":"6","author":"Johnson","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0066","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0067","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jgh3.12141","article-title":"Systematic review with meta-analysis: safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas","volume":"3","author":"Ciccocioppo","year":"2019","journal-title":"JGH Open"},{"issue":"10","key":"2022061709080694700_stem3354-bib-0068","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1007\/s12035-019-1554-x","article-title":"Advances, challenges, and perspectives in translational stem cell therapy for amyotrophic lateral sclerosis","volume":"56","author":"Abati","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0069","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/stem.2475","article-title":"Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons","volume":"35","author":"de Windt","year":"2017","journal-title":"Stem Cells"},{"key":"2022061709080694700_stem3354-bib-0070","article-title":"Treatment of critical limb ischemia with localized scleroderma by local injection of umbilical cord mesenchymal stem cells","author":"Hu","year":"2020","journal-title":"Med Clin"},{"issue":"11","key":"2022061709080694700_stem3354-bib-0071","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5966\/sctm.2013-0033","article-title":"Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels","volume":"2","author":"Bustos","year":"2013","journal-title":"Stem Cells Translational Medicine"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0072","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1165\/rcmb.2012-0406OC","article-title":"Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury","volume":"49","author":"Martinez-Gonzalez","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"2022061709080694700_stem3354-bib-0073","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0074","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/cells9040924","article-title":"Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use","volume":"9","author":"Bari","year":"2020","journal-title":"Cell"},{"issue":"8","key":"2022061709080694700_stem3354-bib-0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5483\/BMBRep.2020.53.8.121","article-title":"Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment","volume":"53","author":"Jayaramayya","year":"2020","journal-title":"BMB Rep"},{"key":"2022061709080694700_stem3354-bib-0076","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2020.06.036","article-title":"Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?","volume":"325","author":"Muraca","year":"2020","journal-title":"J Control Release"},{"key":"2022061709080694700_stem3354-bib-0077","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.reth.2020.03.012","article-title":"Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles","volume":"14","author":"Watanabe","year":"2020","journal-title":"Regen Ther"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0078","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"2022061709080694700_stem3354-bib-0079","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.5966\/sctm.2015-0138","article-title":"Treatment with human Wharton's jelly-derived mesenchymal stem cells attenuates sepsis-induced kidney injury, liver injury, and endothelial dysfunction","volume":"5","author":"Condor","year":"2016","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"10229","key":"2022061709080694700_stem3354-bib-0081","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2022061709080694700_stem3354-bib-0082","doi-asserted-by":"crossref","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"issue":"10","key":"2022061709080694700_stem3354-bib-0083","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/sctm.18-0015","article-title":"Clinical cellular therapeutics accelerate clot formation","volume":"7","author":"George","year":"2018","journal-title":"Stem Cells Translational Medicine"},{"issue":"19","key":"2022061709080694700_stem3354-bib-0084","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0086","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","article-title":"Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism","volume":"431","author":"Tatsumi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0087","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.transproceed.2017.03.078","article-title":"Thromboembolism induced by umbilical cord mesenchymal stem cell infusion: a report of two cases and literature review","volume":"49","author":"Wu","year":"2017","journal-title":"Transplant Proc"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0088","doi-asserted-by":"crossref","first-page":"e85040","DOI":"10.1371\/journal.pone.0085040","article-title":"Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?","volume":"9","author":"Moll","year":"2014","journal-title":"PLoS One"},{"issue":"29","key":"2022061709080694700_stem3354-bib-0089","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0704581104","article-title":"Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts","volume":"104","author":"Hashi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-018-0936-8","article-title":"Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine","volume":"9","author":"Netsch","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0091","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"2022061709080694700_stem3354-bib-0092","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1073\/pnas.1601911113","article-title":"Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo","volume":"113","author":"Chan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0093","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13287-016-0395-z","article-title":"Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice","volume":"7","author":"Li","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0094","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/infdis\/jiy478","article-title":"Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury","volume":"219","author":"Loy","year":"2019","journal-title":"J Infect Dis"},{"issue":"9","key":"2022061709080694700_stem3354-bib-0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4252\/wjsc.v12.i9.1013","article-title":"Perspectives on mesenchymal stem\/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19","volume":"12","author":"Klimczak","year":"2020","journal-title":"World J Stem Cells"},{"key":"2022061709080694700_stem3354-bib-0096","volume-title":"83% Survival in COVID-19 Patients with Moderate\/Severe Acute Respiratory Distress Syndrome Treated in New York with Mesoblast's Cell Therapy Remestemcel-L","author":"Mesoblast","year":"2020"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0097","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1111\/trf.13562","article-title":"Adult adherent cell therapy for ischemic stroke: clinical results and development experience using MultiStem","volume":"56","author":"Mays","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0098","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s13063-020-04380-5","article-title":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (phase I\/II)","volume":"21","author":"Ye","year":"2020","journal-title":"Trials"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0099","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14336\/AD.2020.0301","article-title":"Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia","volume":"11","author":"Shetty","year":"2020","journal-title":"Aging Dis"},{"issue":"5","key":"2022061709080694700_stem3354-bib-0101","doi-asserted-by":"crossref","first-page":"e0233263","DOI":"10.1371\/journal.pone.0233263","article-title":"Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI","volume":"15","author":"Ruppert","year":"2020","journal-title":"PLoS One"},{"issue":"31","key":"2022061709080694700_stem3354-bib-0102","doi-asserted-by":"crossref","first-page":"e21429","DOI":"10.1097\/MD.0000000000021429","article-title":"Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report","volume":"99","author":"Liang","year":"2020","journal-title":"Medicine"},{"key":"2022061709080694700_stem3354-bib-0103","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/DCR.0000000000001700","article-title":"Mesenchymal stem cell therapy can transcend perianal Crohn's disease: how colorectal surgeons can help in the COVID-19 crisis","volume":"63","author":"Lightner","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0104","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2020.1761322","article-title":"Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia","volume":"20","author":"Gentile","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jcp.24794","article-title":"MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS","volume":"230","author":"He","year":"2015","journal-title":"J Cell Physiol"},{"issue":"4","key":"2022061709080694700_stem3354-bib-0106","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3892\/mmr.2014.3025","article-title":"Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury","volume":"11","author":"Min","year":"2015","journal-title":"Mol Med Rep"},{"issue":"6494","key":"2022061709080694700_stem3354-bib-0107","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1126\/science.abc6141","article-title":"The search for a COVID-19 animal model","volume":"368","author":"Lakdawala","year":"2020","journal-title":"Science"},{"key":"2022061709080694700_stem3354-bib-0108","doi-asserted-by":"crossref","first-page":"2000858","DOI":"10.1183\/13993003.00858-2020","article-title":"Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19","volume":"55","author":"Khoury","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0109","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/rccm.201701-0107CP","article-title":"Fifty years of research in ARDS. Cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value","volume":"196","author":"Laffey","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061709080694700_stem3354-bib-0110","volume-title":"Hace2 Transgenic Mouse Model For Coronavirus (COVID-19) Research. 2020","author":"Wang"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0111","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1148\/radiol.2020200843","article-title":"Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study","volume":"296","author":"Wang","year":"2020","journal-title":"Radiology"},{"key":"2022061709080694700_stem3354-bib-0112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fimmu.2017.00313","article-title":"The impact of the interferon\/TNF-related apoptosis-inducing ligand signaling axis on disease progression in respiratory viral infection and beyond","volume":"8","author":"Peteranderl","year":"2017","journal-title":"Front Immunol"},{"issue":"14","key":"2022061709080694700_stem3354-bib-0113","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1128\/JVI.79.14.9320-9324.2005","article-title":"Identification of TRAIL as an interferon regulatory factor 3 transcriptional target","volume":"79","author":"Kirshner","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2172-10-35","article-title":"Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells","volume":"10","author":"Law","year":"2009","journal-title":"BMC Immunol"},{"issue":"9","key":"2022061709080694700_stem3354-bib-0115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bbamcr.2009.02.008","article-title":"Autophagy, antiviral immunity, and viral countermeasures","volume":"1793","author":"Shoji-Kawata","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2022061709080694700_stem3354-bib-0116","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.18632\/oncotarget.7031","article-title":"Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells","volume":"7","author":"Kaczorowski","year":"2016","journal-title":"Oncotarget"},{"issue":"pt 6","key":"2022061709080694700_stem3354-bib-0117","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/brain\/awv094","article-title":"Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells","volume":"138","author":"Bagci-Onder","year":"2015","journal-title":"Brain"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0118","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7150\/thno.27576","article-title":"MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma","volume":"9","author":"Rossignoli","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"2022061709080694700_stem3354-bib-0119","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40635-017-0155-0","article-title":"Whole blood microRNA markers are associated with acute respiratory distress syndrome","volume":"5","author":"Zhu","year":"2017","journal-title":"Intensive Care Med Exp"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201410-1765OC","article-title":"Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice","volume":"192","author":"Monsel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2022061709080694700_stem3354-bib-0121","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","article-title":"Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer","volume":"196","author":"Morrison","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2022061709080694700_stem3354-bib-0122","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/stem.2619","article-title":"Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA","volume":"35","author":"Tang","year":"2017","journal-title":"Stem Cells"},{"key":"2022061709080694700_stem3354-bib-0123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2019.01.022","article-title":"Mesenchymal stromal cells-derived exosomes alleviate ischemia\/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p","volume":"852","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2022061709080694700_stem3354-bib-0124","doi-asserted-by":"crossref","first-page":"111454","DOI":"10.1016\/j.yexcr.2019.05.035","article-title":"Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3","volume":"383","author":"Yi","year":"2019","journal-title":"Exp Cell Res"},{"issue":"15","key":"2022061709080694700_stem3354-bib-0125","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2022061709080694700_stem3354-bib-0126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imm.13223","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China","volume":"160","author":"Tan","year":"2020","journal-title":"Immunology"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.3354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.3354","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/39\/6\/707\/44114479\/stmcls_39_6_707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/39\/6\/707\/44114479\/stmcls_39_6_707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:10:14Z","timestamp":1655457014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/39\/6\/707\/6423746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":126,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3,7]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.3354","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"2020-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}